Page last updated: 2024-08-25

corilagin and Cystic Fibrosis

corilagin has been researched along with Cystic Fibrosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bianchi, N; Borgatti, M; Brognara, E; Chui, CH; Fabbri, E; Fong, WF; Gambari, R; Hau, DK; Kan, CW; Lampronti, I; Piccagli, L; Wong, RS; Wong, WY; Yuen, MC	1

Other Studies

1 other study(ies) available for corilagin and Cystic Fibrosis

Article	Year
Corilagin is a potent inhibitor of NF-kappaB activity and downregulates TNF-alpha induced expression of IL-8 gene in cystic fibrosis IB3-1 cells. International immunopharmacology, 2012, Volume: 13, Issue:3 Topics: Anti-Inflammatory Agents, Non-Steroidal; Base Sequence; Cell Line; Chemokine CCL2; Chemokine CCL5; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Down-Regulation; Glucosides; Humans; Hydrolyzable Tannins; Interleukin-8; Mutation; NF-kappa B; RNA, Messenger; Tumor Necrosis Factor-alpha	2012

Article

Year

Corilagin is a potent inhibitor of NF-kappaB activity and downregulates TNF-alpha induced expression of IL-8 gene in cystic fibrosis IB3-1 cells.

International immunopharmacology, 2012, Volume: 13, Issue:3

Topics: Anti-Inflammatory Agents, Non-Steroidal; Base Sequence; Cell Line; Chemokine CCL2; Chemokine CCL5; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Down-Regulation; Glucosides; Humans; Hydrolyzable Tannins; Interleukin-8; Mutation; NF-kappa B; RNA, Messenger; Tumor Necrosis Factor-alpha

2012